-
1 Comment
Second Sight Medical Products, Inc is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.
From a valuation standpoint, the stock is 87.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 167.4.
Second Sight Medical Products, Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 83.6% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 80.6% to $-1M since the same quarter in the previous year.
Based on the above factors, Second Sight Medical Products, Inc gets an overall score of 4/5.
The fund is an exchange-traded fund (ETF) that seeks to meet its objective by having Corgi Strategies, LLC (the adviser) actively manage the fund and, under ordinary market conditions, invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of companies materially involved in the development and deployment of technologies that collect, process, secure, analyze, and operationalize data for monitoring, risk management, security, compliance, and operational visibility across public and private environments. It is non-diversified.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EYES using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
